Physician
Manatee Pathology Associates, PA
Manatee Pathology Associates, PA was paid $879K by Medicaid between Jan 2018 and Nov 2024, across 103 billing codes. Its largest line is 0241U, Neonatal screening for hereditary disorders, genomic sequence analysis panel — 17% of everything it billed.
33Billing provider infoMANATEE PATHOLOGY ASSOCIATES, PA
BRADENTON, FL 34208
BRADENTON, FL 34208
33aNPI1285739938assigned 09/14/2006
33bProvider typeAnatomic Pathology & Clinical Pathology Physician
28Total paid$879K
24GClaims563,907
24DCodes billed103
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers
Next to other Anatomic Pathology & Clinical Pathology Physician providers in Florida
Rank by total paid#22 of 207
Median peer was paid$39K
This provider vs. median22×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 22,303 | $5K | |
| 2019 | 71,280 | $91K | |
| 2020 | 103,924 | $105K | |
| 2021 | 70,776 | $94K | |
| 2022 | 100,274 | $184K | |
| 2023 | 117,175 | $246K | |
| 2024incomplete | 78,175 | $154K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 17% | 3,794 | 3,404 | $149K |
| 80053 | Comprehensive metabolic panel | 14% | 49,274 | 24,718 | $123K |
| 80048 | Basic metabolic panel (calcium, ionized) | 6.9% | 27,220 | 13,926 | $61K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 6.1% | 1,622 | 1,322 | $54K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 5.5% | 6,977 | 6,722 | $49K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 5.2% | 7,830 | 7,347 | $46K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 5.1% | 59,946 | 37,789 | $45K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 3.0% | 2,840 | 1,857 | $26K |
| 81001 | 2.6% | 33,780 | 25,981 | $23K | |
| 82962 | 2.2% | 29,281 | 5,135 | $20K | |
| 84484 | 2.0% | 11,885 | 6,890 | $18K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | 1.8% | 20,392 | 15,673 | $16K |
91 more codes
| 81025 | 1.5% | 18,574 | $13K | |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | 1.4% | 2,535 | $12K |
| 83735 | 1.4% | 21,401 | $12K | |
| 82803 | 1.3% | 2,459 | $11K | |
| 85027 | 1.2% | 21,168 | $11K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 1.2% | 3,370 | $11K |
| 87040 | 1.2% | 9,777 | $11K | |
| 87641 | 1.1% | 2,123 | $10K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 7,898 | $9K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 5,579 | $8K |
| 82948 | <1% | 31,952 | $8K | |
| 84702 | <1% | 5,105 | $8K | |
| 88307 | <1% | 178 | $7K | |
| 86850 | <1% | 9,585 | $6K | |
| 83605 | <1% | 6,497 | $6K | |
| 83690 | <1% | 12,274 | $6K | |
| 81003 | <1% | 9,166 | $6K | |
| 86900 | <1% | 14,351 | $6K | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 3,269 | $6K |
| 85730 | <1% | 12,138 | $5K | |
| 85610 | <1% | 15,598 | $5K | |
| 87653 | <1% | 1,223 | $5K | |
| 84100 | <1% | 11,561 | $4K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 2,458 | $4K |
| 86901 | <1% | 14,336 | $4K | |
| 87186 | <1% | 2,829 | $4K | |
| 87430 | <1% | 978 | $4K | |
| 87070 | <1% | 3,397 | $3K | |
| 85060 | <1% | 246 | $3K | |
| 82550 | <1% | 3,639 | $2K | |
| 87420 | <1% | 587 | $2K | |
| 80061 | Lipid panel | <1% | 1,065 | $2K |
| 87899 | <1% | 1,003 | $2K | |
| 88342 | <1% | 125 | $2K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 1,813 | $2K |
| 82247 | <1% | 1,912 | $2K | |
| 80074 | <1% | 188 | $2K | |
| 85014 | <1% | 7,572 | $1K | |
| 85018 | <1% | 7,646 | $1K | |
| 86592 | <1% | 3,175 | $1K | |
| 87077 | <1% | 1,342 | $1K | |
| 82248 | <1% | 2,007 | $1K | |
| 87480 | <1% | 305 | $1K | |
| 85379 | <1% | 1,945 | $1K | |
| 85384 | <1% | 1,123 | $1K | |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | <1% | 33 | $983.81 |
| 86141 | <1% | 1,229 | $972.03 | |
| 87340 | <1% | 839 | $968.26 | |
| 82140 | <1% | 691 | $933.14 | |
| 82728 | <1% | 1,161 | $898.24 | |
| 87205 | <1% | 1,677 | $749.28 | |
| 87660 | <1% | 403 | $734.66 | |
| 80202 | <1% | 294 | $731.14 | |
| 84439 | <1% | 743 | $601.72 | |
| 87510 | <1% | 302 | $583.22 | |
| 87561 | <1% | 68 | $563.14 | |
| 84466 | <1% | 389 | $549.62 | |
| 84550 | <1% | 1,252 | $534.37 | |
| 82607 | <1% | 353 | $512.98 | |
| 83615 | <1% | 925 | $490.19 | |
| 83880 | <1% | 1,220 | $471.27 | |
| 83540 | <1% | 761 | $442.91 | |
| 82746 | <1% | 273 | $420.53 | |
| 85007 | <1% | 657 | $408.40 | |
| 88304 | <1% | 96 | $371.98 | |
| 83970 | <1% | 52 | $364.17 | |
| 87634 | <1% | 1,950 | $348.50 | |
| 82570 | <1% | 634 | $335.87 | |
| 84112 | <1% | 425 | $314.14 | |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 270 | $300.45 |
| 85651 | <1% | 823 | $271.65 | |
| 85045 | <1% | 548 | $266.15 | |
| 84156 | <1% | 619 | $234.00 | |
| 88302 | <1% | 44 | $218.67 | |
| 82150 | <1% | 248 | $168.59 | |
| 80076 | <1% | 126 | $136.14 | |
| 86880 | <1% | 134 | $104.97 | |
| 87210 | <1% | 141 | $102.31 | |
| 86762 | <1% | 49 | $94.87 | |
| 86870 | <1% | 27 | $74.08 | |
| 83930 | <1% | 82 | $60.34 | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 31 | $60.31 |
| 84132 | <1% | 244 | $52.65 | |
| 84478 | <1% | 94 | $42.68 | |
| 82010 | <1% | 86 | $31.04 | |
| 86923 | <1% | 713 | $21.25 | |
| 82565 | <1% | 59 | $14.60 | |
| 87806 | <1% | 82 | $13.98 | |
| 87147 | <1% | 16 | $9.68 | |
| 87154 | <1% | 13 | $4.57 | |
| 84145 | 0% | 718 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialFARRELL, THOMAS (AUTHORIZED OFFICIAL)
| Provider | Location | Paid |
|---|---|---|
| Manatee Pathology Associates PA | Bradenton, FL | $3K |
| Manatee Pathology Associates, PA | Wimauma, FL | $2K |
| Manatee Pathology Associates PA | Lakewood Ranch, FL | $746.98 |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.